Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises BHG Group on directed share issue
Mandate

Vinge advises BHG Group on directed share issue

February 04, 2021 Capital Markets and Public M&A

Vinge advises BHG Group AB (publ) in connection with a directed share issue of approximately SEK 1.6 billion through an accelerated book building procedure, and a coordinated sale of approximately 1.2 million shares as part of the company’s incentive program.

The Vinge team includes Christian Lindhé, Erik Sjöman, Kristian Ford (client responsible partner), Martin Svanberg and Sophia Reutercrona.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026